Your browser doesn't support javascript.
loading
Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment.
Jukic, M M; Opel, N; Ström, J; Carrillo-Roa, T; Miksys, S; Novalen, M; Renblom, A; Sim, S C; Peñas-Lledó, E M; Courtet, P; Llerena, A; Baune, B T; de Quervain, D J; Papassotiropoulos, A; Tyndale, R F; Binder, E B; Dannlowski, U; Ingelman-Sundberg, M.
Afiliação
  • Jukic MM; Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Opel N; Department of Psychiatry, University of Münster, Münster, Germany.
  • Ström J; Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Carrillo-Roa T; Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
  • Miksys S; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Novalen M; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Renblom A; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
  • Sim SC; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Peñas-Lledó EM; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Courtet P; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
  • Llerena A; Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Baune BT; Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • de Quervain DJ; CICAB Clinical Research Center, Extremadura University Hospital and Medical School, Badajoz, Spain.
  • Papassotiropoulos A; CIBERSAM, Madrid, Spain.
  • Tyndale RF; CHU Montpellier, Hôpital Lapeyronie, Psychiatric Emergency and Post-Acute Care Department, Pole Urgence, Montpellier, France.
  • Binder EB; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Dannlowski U; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Ingelman-Sundberg M; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
Mol Psychiatry ; 22(8): 1155-1163, 2017 08.
Article em En | MEDLINE | ID: mdl-27895323

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos de Ansiedade / Citocromo P-450 CYP2C19 Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos de Ansiedade / Citocromo P-450 CYP2C19 Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia